Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections [Corrigendum]

Abstract

Zhou L, Gao Y, Cao W, et al. Infect Drug Resist. 2018;11:29–36.On page 29, the first and second affiliations were listed incorrectly. The correct presentation of affiliations 1 and 2should be as follows:1Translational Medicine Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China;2Department of Respiratory Medicine, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, ChinaOn page 29, the second correspondence author’s name should read from Long Chen to Long Cheng.Read the original article